NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

妊娠毒血症的實驗室檢驗市場-全球產業分析(2017年∼2019年)-成長趨勢與市場預測(2020年∼2025年)

Preeclampsia Laboratory Testing Market - Global Industry Analysis (2017 - 2019) - Growth Trends and Market Forecast (2020 - 2025)

出版商 Fairfield Market Research 商品編碼 1006913
出版日期 內容資訊 英文 145 Pages
商品交期: 最快1-2個工作天內
價格
妊娠毒血症的實驗室檢驗市場-全球產業分析(2017年∼2019年)-成長趨勢與市場預測(2020年∼2025年) Preeclampsia Laboratory Testing Market - Global Industry Analysis (2017 - 2019) - Growth Trends and Market Forecast (2020 - 2025)
出版日期: 2021年04月01日內容資訊: 英文 145 Pages
簡介

全球妊娠毒血症的實驗室檢驗市場,2020年為12億4,000萬美元的銷售額。該市場,預計從2020年到2025年的預測期間順利成長。新興各國的妊娠毒血症的高與盛行率,與對應病例數劇增的一些產品銷售,為該市場的成長要素。還有該市場評估期間中預計以2位數成長,企業確保長期前景很重要。

本報告提供全球妊娠毒血症的實驗室檢驗市場的相關調查,市場趨勢,成長及阻礙因素,各檢驗類型、產品、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 全球妊娠毒血症的實驗室檢驗市場預測(2017-2025)
  • 全球妊娠毒血症的實驗室檢驗市場增量機會(2020-2025)
  • 主要的產業趨勢

第2章 市場概要

  • 市場定義與市場區隔
  • 市場動態
    • 市場成長要素
    • 市場阻礙因素
  • 妊娠毒血症流行病學
  • 法規指南

第3章 全球妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 全球妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 全球妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 全球妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 全球妊娠毒血症的實驗室檢驗市場預測:各地區(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第4章 北美的妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各國(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第5章 歐洲的妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各國(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第6章 亞太地區的妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各國(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第7章 南美的妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各國(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第8章 中東及非洲的妊娠毒血症的實驗室檢驗市場預測(2017-2025)

  • 妊娠毒血症的實驗室檢驗市場預測:各檢驗類型(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各產品(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各終端用戶(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)
  • 妊娠毒血症的實驗室檢驗市場預測:各國(2017-2025)
    • 主要的焦點
    • 市場預測:銷售額(2017-2025)
    • 市場佔有率及BPS分析(2020,2025)
    • 市場魅力分析(2020-2025)

第9章 競爭情形

  • 主要15家公司的企業市場佔有率分析(2019)
  • 策略性合作
  • 企業簡介
    • PerkinElmer Inc.
    • F. Hoffmann-La Roche Ltd.
    • ThermoFischer Scientific Inc.
    • SERA Prognostics
    • Bayer AG,
    • Siemens Healthineers AG
    • Metabolomic Diagnostics Ltd.
    • DiabetOmics Inc.,
    • DRG INSTRUMENTS GMBH
    • Progenity Inc.

第10章 附錄

  • 調查手法
  • 報告特定的研究途徑
目錄

The global preeclampsia laboratory testing market was worth US$ 1.24 billion in 2020 and is poised to grow at a healthy rate for the forecast period from 2020 -2025. The preeclampsia laboratory testing market should benefit primarily from two factors - a high prevalence of preeclampsia in developing countries, coupled with several product launches to cater to this surging caseload. As per the latest insights from Fairfield Market Research, the preeclampsia laboratory testing market will grow by double digits during the assessment period, making it critical for organizations to secure their long-term prospects.

Highlights of Preeclampsia Laboratory Testing Market:

Blood tests are anticipated to remain the leading test category for the foreseeable future

In terms of revenue, North America leads the global preeclampsia laboratory testing market

A few companies profiled in the preeclampsia laboratory testing market comprise Bayer AG, SERA Prognostics, Siemens Healthineers, and DRG Instruments GMBH

Several challenges such as delayed healthcare access, delivery, inadequate implementation, and poor policy guidelines stifle the growth of the preeclampsia laboratory testing market

Three Companies Dominate the Global Preeclampsia Laboratory Testing Market

ThermoFischer Scientific, F. Hoffmann-La Roche, and PerkinElmer have approx. 60% of the global preeclampsia laboratory testing market amongst themselves. Along with these companies, the exhaustive report has also analyzed SERA Prognostics, Bayer AG, Siemens Healthineers AG, Metabolomic Diagnostics Ltd., DiabetOmics Inc., DRG INSTRUMENTS GMBH, and Progenity Inc, amongst others.

Blood Tests the Preferred Test Type in Preeclampsia Laboratory Testing Market

Blood tests hold a sizeable lead in the test type category of the preeclampsia laboratory testing market and this is not projected to change anytime soon. Patients opt for blood tests over other options because of their higher accuracy rates. Furthermore, several novel biomarkers have been launched in the preeclampsia laboratory testing market recently.

Challenging Conditions for Major Stakeholders in Preeclampsia Laboratory Testing Market

A number of constraints inhibit the growth of the global preeclampsia laboratory testing market. The most common ones include slow decision making, delayed access to healthcare, deficient policy guidelines, and improper implementation at both micro and macro levels. This burden is particularly acute in developing countries, where medical interventions are usually ineffective due to a late diagnosis of preeclampsia. An absence of cost-effective preeclampsia screen options, along with an overall lack of awareness in emerging economies, will be the primary challenge that all stakeholders in the preeclampsia laboratory testing market will have to overcome.

North America Holds the Key to Profitability in Preeclampsia Laboratory Testing Market

North America plays a preeminent role in the global preeclampsia laboratory testing market as it is the largest revenue contributor. The North American region was worth US$ 465 million in 2020 alone, and is predicted to grow at a healthy CAGR of 9.6% until 2025. The reasons are twofold - the presence of numerous patient advocacy groups as well as government initiatives to develop a better diagnostics regimen. In 2019, the Food & Drug Association (FDA) approved an advanced prenatal therapeutics (APT) device designation to treat Targeted Apheresis Column for Preeclampsia (TAC-PE).

High Economic Burden Boosts Prospects of Preeclampsia Laboratory Testing Market

The Ethiopian National Emergency Obstetric and Newborn Care states that 10% of maternal mortality is linked to preeclampsia. In India, the incidence of preeclampsia is estimated to be within the range of 8-10%. This problem is not restricted to developing countries alone as the Preeclampsia Foundation states that preeclampsia-related short-term costs are around US$ 2 billion in the U.S. alone.

Table of Contents

1. Executive Summary

  • 1.1. Global Preeclampsia Laboratory Testing Market Outlook, 2017 - 2025 (US$ Million)
  • 1.2. Global Preeclampsia Laboratory Testing Market Incremental Opportunity, 2020 - 2025 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Market Drivers
    • 2.2.2. Market Restraints
  • 2.3. Preeclampsia Epidemiology
  • 2.4. Regulatory Guidelines

3. Global Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 3.1. Global Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 3.1.1. Key Highlights
    • 3.1.2. Global Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 3.1.2.1. Blood Tests
      • 3.1.2.2. Urine Tests
    • 3.1.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 3.1.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 3.2. Global Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 3.2.1. Key Highlights
    • 3.2.2. Global Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 3.2.2.1. Consumables
      • 3.2.2.2. Instruments
    • 3.2.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
    • 3.2.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 3.3. Global Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 3.3.1. Key Highlights
    • 3.3.2. Global Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 3.3.2.1. Hospitals & Clinics
      • 3.3.2.2. Diagnostics Centers
      • 3.3.2.3. Others
    • 3.3.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 3.3.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 3.4. Global Preeclampsia Laboratory Testing Market Outlook, By Region, 2017-2025
    • 3.4.1. Key Highlights
    • 3.4.2. Global Preeclampsia Laboratory Testing Market Outlook, by Region, Value (US$ Million), 2017 - 2025
      • 3.4.2.1. North America
      • 3.4.2.2. Europe
      • 3.4.2.3. Asia Pacific
      • 3.4.2.4. Latin America
      • 3.4.2.5. Middle East & Africa
    • 3.4.3. Global Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Region, 2020 and 2025
    • 3.4.4. Global Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Region, 2020-2025

4. North America Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 4.1. North America Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 4.1.1. Key Highlights
    • 4.1.2. North America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 4.1.2.1. Blood Tests
      • 4.1.2.2. Urine Tests
    • 4.1.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 4.1.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 4.2. North America Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 4.2.1. Key Highlights
    • 4.2.2. North America Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 4.2.2.1. Consumables
      • 4.2.2.2. Instruments
    • 4.2.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
    • 4.2.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 4.3. North America Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 4.3.1. Key Highlights
    • 4.3.2. North America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 4.3.2.1. Hospitals & Clinics
      • 4.3.2.2. Diagnostics Centers
      • 4.3.2.3. Others
    • 4.3.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 4.3.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 4.4. North America Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
    • 4.4.1. Key Highlights
    • 4.4.2. North America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
      • 4.4.2.1. United States
      • 4.4.2.2. Canada
    • 4.4.3. North America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
    • 4.4.4. North America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

5. Europe Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 5.1. Europe Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 5.1.1. Key Highlights
    • 5.1.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 5.1.2.1. Blood Tests
      • 5.1.2.2. Urine Tests
    • 5.1.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 5.1.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 5.2. Europe Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 5.2.1. Key Highlights
    • 5.2.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 5.2.2.1. Consumables
      • 5.2.2.2. Instruments
    • 5.2.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
    • 5.2.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 5.3. Europe Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 5.3.1. Key Highlights
    • 5.3.2. Europe Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 5.3.2.1. Hospitals & Clinics
      • 5.3.2.2. Diagnostics Centers
      • 5.3.2.3. Others
    • 5.3.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 5.3.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 5.4. Europe Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
    • 5.4.1. Key Highlights
    • 5.4.2. Europe Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
      • 5.4.2.1. Germany
      • 5.4.2.2. France
      • 5.4.2.3. United Kingdom
      • 5.4.2.4. Italy
      • 5.4.2.5. Spain
      • 5.4.2.6. Scandinavia
      • 5.4.2.7. Rest of Europe
    • 5.4.3. Europe Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
    • 5.4.4. Europe Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

6. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 6.1. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 6.1.1. Key Highlights
    • 6.1.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 6.1.2.1. Blood Tests
      • 6.1.2.2. Urine Tests
    • 6.1.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 6.1.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 6.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 6.2.1. Key Highlights
    • 6.2.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 6.2.2.1. Consumables
      • 6.2.2.2. Instruments
    • 6.2.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
    • 6.2.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 6.3. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 6.3.1. Key Highlights
    • 6.3.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 6.3.2.1. Hospitals & Clinics
      • 6.3.2.2. Diagnostics Centers
      • 6.3.2.3. Others
    • 6.3.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 6.3.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 6.4. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
    • 6.4.1. Key Highlights
    • 6.4.2. Asia Pacific Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
      • 6.4.2.1. Japan
      • 6.4.2.2. China
      • 6.4.2.3. India
      • 6.4.2.4. Australia & New Zealand
      • 6.4.2.5. South East Asia
      • 6.4.2.6. Rest of Asia Pacific
    • 6.4.3. Asia Pacific Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
    • 6.4.4. Asia Pacific Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

7. Latin America Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 7.1. Latin America Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 7.1.1. Key Highlights
    • 7.1.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 7.1.2.1. Blood Tests
      • 7.1.2.2. Urine Tests
    • 7.1.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 7.1.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 7.2. Latin America Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 7.2.1. Key Highlights
    • 7.2.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 7.2.2.1. Consumables
      • 7.2.2.2. Instruments
    • 7.2.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Product, 2020 and 2025
    • 7.2.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 7.3. Latin America Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 7.3.1. Key Highlights
    • 7.3.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 7.3.2.1. Hospitals & Clinics
      • 7.3.2.2. Diagnostics Centers
      • 7.3.2.3. Others
    • 7.3.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 7.3.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 7.4. Latin America Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
    • 7.4.1. Key Highlights
    • 7.4.2. Latin America Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
      • 7.4.2.1. Brazil
      • 7.4.2.2. Mexico
      • 7.4.2.3. Rest of Latin America
    • 7.4.3. Latin America Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
    • 7.4.4. Latin America Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

8. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, 2017-2025

  • 8.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Test Type, 2017-2025
    • 8.1.1. Key Highlights
    • 8.1.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Test Type, Value (US$ Million), 2017 - 2025
      • 8.1.2.1. Blood Tests
      • 8.1.2.2. Urine Tests
    • 8.1.3. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Test Type, 2020 and 2025
    • 8.1.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Test Type, 2020-2025
  • 8.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Product, 2017-2025
    • 8.2.1. Key Highlights
    • 8.2.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Product, Value (US$ Million), 2017 - 2025
      • 8.2.2.1. Consumables
      • 8.2.2.2. Instruments
    • 8.2.3. Middle East & Africa Share and BPS Analysis, by Product, 2020 and 2025
    • 8.2.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Product, 2020-2025
  • 8.3. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By End User, 2017-2025
    • 8.3.1. Key Highlights
    • 8.3.1. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by End User, Value (US$ Million), 2017 - 2025
      • 8.3.1.1. Hospitals & Clinics
      • 8.3.1.2. Diagnostics Centers
      • 8.3.1.3. Others
    • 8.3.2. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by End User, 2020 and 2025
    • 8.3.3. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by End User, 2020-2025
  • 8.4. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, By Country, 2017-2025
    • 8.4.1. Key Highlights
    • 8.4.2. Middle East & Africa Preeclampsia Laboratory Testing Market Outlook, by Country, Value (US$ Million), 2017 - 2025
      • 8.4.2.1. GCC Countries
      • 8.4.2.2. South Africa
      • 8.4.2.3. Rest of Middle East & Africa
    • 8.4.3. Middle East & Africa Preeclampsia Laboratory Testing Market Share and BPS Analysis, by Country, 2020 and 2025
    • 8.4.4. Middle East & Africa Preeclampsia Laboratory Testing Market Attractiveness Analysis, by Country, 2020-2025

9. Competitive Landscape

  • 9.1. Top 15 Company Market Share Analysis, 2019
  • 9.2. Strategic Collaborations
  • 9.3. Company Profiles
    • 9.3.1. PerkinElmer Inc.
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Test Type Portfolio
      • 9.3.1.4. Recent Developments
    • 9.3.2. F. Hoffmann-La Roche Ltd.
    • 9.3.3. ThermoFischer Scientific Inc.
    • 9.3.4. SERA Prognostics
    • 9.3.5. Bayer AG,
    • 9.3.6. Siemens Healthineers AG
    • 9.3.7. Metabolomic Diagnostics Ltd.
    • 9.3.8. DiabetOmics Inc.,
    • 9.3.9. DRG INSTRUMENTS GMBH
    • 9.3.10. Progenity Inc.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Specific Research Approach